L'Oréal acquires 10% stake in Galderma Group AG

The financial terms were not disclosed.

L'Oréal has acquired a 10% stake in Galderma Group AG from Sunshine SwissCo AG, a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd. The financial terms were not disclosed.

The two groups will also form a strategic scientific partnership, combining Galderma’s dermatological expertise with L'Oréal’s knowledge in skin biology and diagnostic tools.

Known for its leadership in the beauty industry and innovative approach to Beauty Tech, L'Oréal is expanding its holistic beauty routine, including integrating diagnostic tools, high-performance topical products, consumer devices, and aesthetic treatments to address and prevent skin aging.

With support from the EQT-led consortium, Galderma boasts a wide range of dermo-cosmetics, dermatologic drugs, and top-tier hyaluronic acid fillers, neuromodulators, and biostimulators.

Galderma welcomes L'Oréal as a long-term partner. L'Oréal will not seek representation on Galderma’s Board of Directors and has agreed to standard investment provisions.

The transaction, funded by L'Oréal’s cash and credit lines, is expected to close in the coming days.